• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROSA VALVE; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROSA VALVE; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV701T
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Hydrocephalus (3272)
Event Date 08/28/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Manufacturing site evaluation: investigation on-going.Additional information / investigation results will be provided in a supplemental report.
 
Event Description
It was reported that there was an unspecified issue with the shunt system.A prosa valve was being returned to the manufacturer and the surgeon requested that it be "checked for protein".Additional information is expected upon receipt of the return kit.
 
Manufacturer Narrative
Reason for complaint: suspician of occlusion.Date of removal: (b)(6) 2019.Manufacturing evaluation: the valve was received submersed in an unidentified liquid.Visual inspection - a deformation of the outer casing was detected.The valve housing was subsequently measured and confirmed the presence of a deformation, outside the tolerance.Permeability test - results have shown that the valve was permeable.Adjustment test - the valve was not fully adjustable to specifications.Braking force and function test - the brake function was operational, but the braking force could not be measured due to the non-adjustability.Results - after the tests, we have dismantled the valve.Inside the valve we found a significant build-up of substances (likely protein).Based on our investigation, we are unable to confirm that the valve was blocked.However, it is possible that the deposits observed inside the valves could have caused the observed malfunction in the past and led to a temporary blockage.As described in our literature, the problem encountered is one of the known, inevitable risks of hydrocephalus (hc) therapy by shunt implants.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROSA VALVE
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key9105468
MDR Text Key160051829
Report Number3004721439-2019-00242
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 11/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFV701T
Device Catalogue NumberFV701T
Was Device Available for Evaluation? Yes
Date Manufacturer Received10/07/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-